弱毒化生ワクチンの世界市場:販売動向2017

【英語タイトル】Global Live Attenuated Vaccine Sales Market Report 2017

QYResearchが出版した調査資料(QYR70323056)・商品コード:QYR70323056
・発行会社(調査会社):QYResearch
・発行日:2017年2月20日
・ページ数:107
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥848,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、弱毒化生ワクチンの世界市場について調査・分析し、弱毒化生ワクチンのメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、弱毒化生ワクチン産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・弱毒化生ワクチン市場概要
・弱毒化生ワクチンのメーカー別販売量・メーカー別シェア
・弱毒化生ワクチンの世界市場:種類別販売量・市場シェア
・弱毒化生ワクチンの世界市場:用途別販売量・市場シェア
・弱毒化生ワクチンの世界市場:地域別販売量・市場シェア
・弱毒化生ワクチンのアメリカ市場規模
・弱毒化生ワクチンの中国市場規模
・弱毒化生ワクチンのヨーロッパ市場規模
・弱毒化生ワクチンの日本市場規模
・弱毒化生ワクチンの東南アジア市場規模
・弱毒化生ワクチンのインド市場規模
・弱毒化生ワクチンのメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・弱毒化生ワクチンのコスト分析・価格動向
・弱毒化生ワクチンの産業チェーン(サプライチェーン分析)
・弱毒化生ワクチンのマーケティング戦略・販売チャネル、流通業者
・弱毒化生ワクチン市場への影響要因分析
・弱毒化生ワクチンの世界市場予測
・弱毒化生ワクチンのアメリカ市場予測
・弱毒化生ワクチンの中国市場予測
・弱毒化生ワクチンのヨーロッパ市場予測
・弱毒化生ワクチンの日本市場予測
・弱毒化生ワクチンの東南アジア市場予測
・弱毒化生ワクチンのインド市場予測
・弱毒化生ワクチンの種類別世界市場予測
・弱毒化生ワクチンの用途別世界市場予測
...
【レポートの概要】

Notes:Sales, means the sales volume of Live Attenuated Vaccine
Revenue, means the sales value of Live Attenuated Vaccine

This report studies sales (consumption) of Live Attenuated Vaccine in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Astellas Pharma Inc
CSL Limited
Emergent BioSolutions
GlaxoSmithKline
Johnson&Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Live Attenuated Vaccine in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Live Attenuated Vaccine in each application, can be divided into
Application 1
Application 2

【レポートの目次】

Table of Contents

Global Live Attenuated Vaccine Sales Market Report 2017
1 Live Attenuated Vaccine Overview
1.1 Product Overview and Scope of Live Attenuated Vaccine
1.2 Classification of Live Attenuated Vaccine
1.2.1 Type I
1.2.2 Type II
1.3 Application of Live Attenuated Vaccine
1.3.1 Application 1
1.3.2 Application 2
1.4 Live Attenuated Vaccine Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Live Attenuated Vaccine (2012-2022)
1.5.1 Global Live Attenuated Vaccine Sales and Growth Rate (2012-2022)
1.5.2 Global Live Attenuated Vaccine Revenue and Growth Rate (2012-2022)

2 Global Live Attenuated Vaccine Competition by Manufacturers, Type and Application
2.1 Global Live Attenuated Vaccine Market Competition by Manufacturers
2.1.1 Global Live Attenuated Vaccine Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Live Attenuated Vaccine Revenue and Share by Manufacturers (2012-2017)
2.2 Global Live Attenuated Vaccine (Volume and Value) by Type
2.2.1 Global Live Attenuated Vaccine Sales and Market Share by Type (2012-2017)
2.2.2 Global Live Attenuated Vaccine Revenue and Market Share by Type (2012-2017)
2.3 Global Live Attenuated Vaccine (Volume and Value) by Regions
2.3.1 Global Live Attenuated Vaccine Sales and Market Share by Regions (2012-2017)
2.3.2 Global Live Attenuated Vaccine Revenue and Market Share by Regions (2012-2017)
2.4 Global Live Attenuated Vaccine (Volume) by Application

3 United States Live Attenuated Vaccine (Volume, Value and Sales Price)
3.1 United States Live Attenuated Vaccine Sales and Value (2012-2017)
3.1.1 United States Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
3.1.2 United States Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
3.1.3 United States Live Attenuated Vaccine Sales Price Trend (2012-2017)
3.2 United States Live Attenuated Vaccine Sales and Market Share by Manufacturers
3.3 United States Live Attenuated Vaccine Sales and Market Share by Type
3.4 United States Live Attenuated Vaccine Sales and Market Share by Application

4 China Live Attenuated Vaccine (Volume, Value and Sales Price)
4.1 China Live Attenuated Vaccine Sales and Value (2012-2017)
4.1.1 China Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
4.1.2 China Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
4.1.3 China Live Attenuated Vaccine Sales Price Trend (2012-2017)
4.2 China Live Attenuated Vaccine Sales and Market Share by Manufacturers
4.3 China Live Attenuated Vaccine Sales and Market Share by Type
4.4 China Live Attenuated Vaccine Sales and Market Share by Application

5 Europe Live Attenuated Vaccine (Volume, Value and Sales Price)
5.1 Europe Live Attenuated Vaccine Sales and Value (2012-2017)
5.1.1 Europe Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
5.1.2 Europe Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
5.1.3 Europe Live Attenuated Vaccine Sales Price Trend (2012-2017)
5.2 Europe Live Attenuated Vaccine Sales and Market Share by Manufacturers
5.3 Europe Live Attenuated Vaccine Sales and Market Share by Type
5.4 Europe Live Attenuated Vaccine Sales and Market Share by Application

6 Japan Live Attenuated Vaccine (Volume, Value and Sales Price)
6.1 Japan Live Attenuated Vaccine Sales and Value (2012-2017)
6.1.1 Japan Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
6.1.2 Japan Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
6.1.3 Japan Live Attenuated Vaccine Sales Price Trend (2012-2017)
6.2 Japan Live Attenuated Vaccine Sales and Market Share by Manufacturers
6.3 Japan Live Attenuated Vaccine Sales and Market Share by Type
6.4 Japan Live Attenuated Vaccine Sales and Market Share by Application
7 Southeast Asia Live Attenuated Vaccine (Volume, Value and Sales Price)
7.1 Southeast Asia Live Attenuated Vaccine Sales and Value (2012-2017)
7.1.1 Southeast Asia Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Live Attenuated Vaccine Sales Price Trend (2012-2017)
7.2 Southeast Asia Live Attenuated Vaccine Sales and Market Share by Manufacturers
7.3 Southeast Asia Live Attenuated Vaccine Sales and Market Share by Type
7.4 Southeast Asia Live Attenuated Vaccine Sales and Market Share by Application
8 India Live Attenuated Vaccine (Volume, Value and Sales Price)
8.1 India Live Attenuated Vaccine Sales and Value (2012-2017)
8.1.1 India Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
8.1.2 India Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
8.1.3 India Live Attenuated Vaccine Sales Price Trend (2012-2017)
8.2 India Live Attenuated Vaccine Sales and Market Share by Manufacturers
8.3 India Live Attenuated Vaccine Sales and Market Share by Type
8.4 India Live Attenuated Vaccine Sales and Market Share by Application

9 Global Live Attenuated Vaccine Manufacturers Analysis
9.1 Astellas Pharma Inc
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Live Attenuated Vaccine Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Astellas Pharma Inc Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 CSL Limited
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Live Attenuated Vaccine Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 CSL Limited Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Emergent BioSolutions
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Live Attenuated Vaccine Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Emergent BioSolutions Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Live Attenuated Vaccine Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 GlaxoSmithKline Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Johnson&Johnson
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Live Attenuated Vaccine Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Johnson&Johnson Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 MedImmune
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Live Attenuated Vaccine Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 MedImmune Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Merck
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Live Attenuated Vaccine Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Merck Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Pfizer
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Live Attenuated Vaccine Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Pfizer Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Sanofi Pasteur
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Live Attenuated Vaccine Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Sanofi Pasteur Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview

10 Live Attenuated Vaccine Maufacturing Cost Analysis
10.1 Live Attenuated Vaccine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Live Attenuated Vaccine
10.3 Manufacturing Process Analysis of Live Attenuated Vaccine

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Live Attenuated Vaccine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Live Attenuated Vaccine Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Live Attenuated Vaccine Market Forecast (2017-2022)
14.1 Global Live Attenuated Vaccine Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Live Attenuated Vaccine Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Live Attenuated Vaccine Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Live Attenuated Vaccine Price and Trend Forecast (2017-2022)
14.2 Global Live Attenuated Vaccine Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Live Attenuated Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Live Attenuated Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Live Attenuated Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Live Attenuated Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Live Attenuated Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Live Attenuated Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Live Attenuated Vaccine Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Live Attenuated Vaccine Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Live Attenuated Vaccine
Table Classification of Live Attenuated Vaccine
Figure Global Sales Market Share of Live Attenuated Vaccine by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Live Attenuated Vaccine
Figure Global Sales Market Share of Live Attenuated Vaccine by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Live Attenuated Vaccine Revenue and Growth Rate (2012-2022)
Figure China Live Attenuated Vaccine Revenue and Growth Rate (2012-2022)
Figure Europe Live Attenuated Vaccine Revenue and Growth Rate (2012-2022)
Figure Japan Live Attenuated Vaccine Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Live Attenuated Vaccine Revenue and Growth Rate (2012-2022)
Figure India Live Attenuated Vaccine Revenue and Growth Rate (2012-2022)
Figure Global Live Attenuated Vaccine Sales and Growth Rate (2012-2022)
Figure Global Live Attenuated Vaccine Revenue and Growth Rate (2012-2022)
Table Global Live Attenuated Vaccine Sales of Key Manufacturers (2012-2017)
Table Global Live Attenuated Vaccine Sales Share by Manufacturers (2012-2017)
Figure 2015 Live Attenuated Vaccine Sales Share by Manufacturers
Figure 2016 Live Attenuated Vaccine Sales Share by Manufacturers
Table Global Live Attenuated Vaccine Revenue by Manufacturers (2012-2017)
Table Global Live Attenuated Vaccine Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Live Attenuated Vaccine Revenue Share by Manufacturers
Table 2016 Global Live Attenuated Vaccine Revenue Share by Manufacturers
Table Global Live Attenuated Vaccine Sales and Market Share by Type (2012-2017)
Table Global Live Attenuated Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Live Attenuated Vaccine by Type (2012-2017)
Figure Global Live Attenuated Vaccine Sales Growth Rate by Type (2012-2017)
Table Global Live Attenuated Vaccine Revenue and Market Share by Type (2012-2017)
Table Global Live Attenuated Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Live Attenuated Vaccine by Type (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Growth Rate by Type (2012-2017)
Table Global Live Attenuated Vaccine Sales and Market Share by Regions (2012-2017)
Table Global Live Attenuated Vaccine Sales Share by Regions (2012-2017)
Figure Sales Market Share of Live Attenuated Vaccine by Regions (2012-2017)
Figure Global Live Attenuated Vaccine Sales Growth Rate by Regions (2012-2017)
Table Global Live Attenuated Vaccine Revenue and Market Share by Regions (2012-2017)
Table Global Live Attenuated Vaccine Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Live Attenuated Vaccine by Regions (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Growth Rate by Regions (2012-2017)
Table Global Live Attenuated Vaccine Sales and Market Share by Application (2012-2017)
Table Global Live Attenuated Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Live Attenuated Vaccine by Application (2012-2017)
Figure Global Live Attenuated Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
Figure United States Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
Figure United States Live Attenuated Vaccine Sales Price Trend (2012-2017)
Table United States Live Attenuated Vaccine Sales by Manufacturers (2012-2017)
Table United States Live Attenuated Vaccine Market Share by Manufacturers (2012-2017)
Table United States Live Attenuated Vaccine Sales by Type (2012-2017)
Table United States Live Attenuated Vaccine Market Share by Type (2012-2017)
Table United States Live Attenuated Vaccine Sales by Application (2012-2017)
Table United States Live Attenuated Vaccine Market Share by Application (2012-2017)
Figure China Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
Figure China Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
Figure China Live Attenuated Vaccine Sales Price Trend (2012-2017)
Table China Live Attenuated Vaccine Sales by Manufacturers (2012-2017)
Table China Live Attenuated Vaccine Market Share by Manufacturers (2012-2017)
Table China Live Attenuated Vaccine Sales by Type (2012-2017)
Table China Live Attenuated Vaccine Market Share by Type (2012-2017)
Table China Live Attenuated Vaccine Sales by Application (2012-2017)
Table China Live Attenuated Vaccine Market Share by Application (2012-2017)
Figure Europe Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
Figure Europe Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
Figure Europe Live Attenuated Vaccine Sales Price Trend (2012-2017)
Table Europe Live Attenuated Vaccine Sales by Manufacturers (2012-2017)
Table Europe Live Attenuated Vaccine Market Share by Manufacturers (2012-2017)
Table Europe Live Attenuated Vaccine Sales by Type (2012-2017)
Table Europe Live Attenuated Vaccine Market Share by Type (2012-2017)
Table Europe Live Attenuated Vaccine Sales by Application (2012-2017)
Table Europe Live Attenuated Vaccine Market Share by Application (2012-2017)
Figure Japan Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
Figure Japan Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
Figure Japan Live Attenuated Vaccine Sales Price Trend (2012-2017)
Table Japan Live Attenuated Vaccine Sales by Manufacturers (2012-2017)
Table Japan Live Attenuated Vaccine Market Share by Manufacturers (2012-2017)
Table Japan Live Attenuated Vaccine Sales by Type (2012-2017)
Table Japan Live Attenuated Vaccine Market Share by Type (2012-2017)
Table Japan Live Attenuated Vaccine Sales by Application (2012-2017)
Table Japan Live Attenuated Vaccine Market Share by Application (2012-2017)
Figure Southeast Asia Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
Figure Southeast Asia Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Live Attenuated Vaccine Sales Price Trend (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Sales by Manufacturers (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Market Share by Manufacturers (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Sales by Type (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Market Share by Type (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Sales by Application (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Market Share by Application (2012-2017)
Figure India Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
Figure India Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
Figure India Live Attenuated Vaccine Sales Price Trend (2012-2017)
Table India Live Attenuated Vaccine Sales by Manufacturers (2012-2017)
Table India Live Attenuated Vaccine Market Share by Manufacturers (2012-2017)
Table India Live Attenuated Vaccine Sales by Type (2012-2017)
Table India Live Attenuated Vaccine Market Share by Type (2012-2017)
Table India Live Attenuated Vaccine Sales by Application (2012-2017)
Table India Live Attenuated Vaccine Market Share by Application (2012-2017)
Table Astellas Pharma Inc Basic Information List
Table Astellas Pharma Inc Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Pharma Inc Live Attenuated Vaccine Global Market Share (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Limited Live Attenuated Vaccine Global Market Share (2012-2017)
Table Emergent BioSolutions Basic Information List
Table Emergent BioSolutions Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Emergent BioSolutions Live Attenuated Vaccine Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Live Attenuated Vaccine Global Market Share (2012-2017)
Table Johnson&Johnson Basic Information List
Table Johnson&Johnson Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson&Johnson Live Attenuated Vaccine Global Market Share (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure MedImmune Live Attenuated Vaccine Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Live Attenuated Vaccine Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Live Attenuated Vaccine Global Market Share (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Pasteur Live Attenuated Vaccine Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Live Attenuated Vaccine
Figure Manufacturing Process Analysis of Live Attenuated Vaccine
Figure Live Attenuated Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Live Attenuated Vaccine Major Manufacturers in 2015
Table Major Buyers of Live Attenuated Vaccine
Table Distributors/Traders List
Figure Global Live Attenuated Vaccine Sales and Growth Rate Forecast (2017-2022)
Figure Global Live Attenuated Vaccine Revenue and Growth Rate Forecast (2017-2022)
Table Global Live Attenuated Vaccine Sales Forecast by Regions (2017-2022)
Table Global Live Attenuated Vaccine Sales Forecast by Type (2017-2022)
Table Global Live Attenuated Vaccine Sales Forecast by Application (2017-2022)



★調査レポート[弱毒化生ワクチンの世界市場:販売動向2017] (コード:QYR70323056)販売に関する免責事項を必ずご確認ください。
★調査レポート[弱毒化生ワクチンの世界市場:販売動向2017]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆